Mustang Bio (MBIO) Reports Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight – StreetInsider.com
|
Mustang Bio (MBIO) Reports Preclinical Data on Potency of its CAR T Cells in Glioblastoma Published in JCI Insight
StreetInsider.com Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (CAR T) technology, today announced … |
